These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 9810003)

  • 1. Differences in susceptibility to tumor necrosis factor alpha-induced apoptosis among MCF-7 breast cancer cell variants.
    Burow ME; Weldon CB; Tang Y; Navar GL; Krajewski S; Reed JC; Hammond TG; Clejan S; Beckman BS
    Cancer Res; 1998 Nov; 58(21):4940-6. PubMed ID: 9810003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitization of apoptotically-resistant breast carcinoma cells to TNF and TRAIL by inhibition of p38 mitogen-activated protein kinase signaling.
    Weldon CB; Parker AP; Patten D; Elliott S; Tang Y; Frigo DE; Dugan CM; Coakley EL; Butler NN; Clayton JL; Alam J; Curiel TJ; Beckman BS; Jaffe BM; Burow ME
    Int J Oncol; 2004 Jun; 24(6):1473-80. PubMed ID: 15138590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor-alpha sensitizes prostate cancer cells to gamma-irradiation-induced apoptosis.
    Kimura K; Bowen C; Spiegel S; Gelmann EP
    Cancer Res; 1999 Apr; 59(7):1606-14. PubMed ID: 10197636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of transforming growth factor beta signaling in MCF-7 cells results in resistance to tumor necrosis factor alpha: a role for Bcl-2.
    Tobin SW; Brown MK; Douville K; Payne DC; Eastman A; Arrick BA
    Cell Growth Differ; 2001 Feb; 12(2):109-17. PubMed ID: 11243465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor-alpha induces the expression of DR6, a member of the TNF receptor family, through activation of NF-kappaB.
    Kasof GM; Lu JJ; Liu D; Speer B; Mongan KN; Gomes BC; Lorenzi MV
    Oncogene; 2001 Nov; 20(55):7965-75. PubMed ID: 11753679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.
    Hamaï A; Richon C; Meslin F; Faure F; Kauffmann A; Lecluse Y; Jalil A; Larue L; Avril MF; Chouaib S; Mehrpour M
    Oncogene; 2006 Dec; 25(58):7618-34. PubMed ID: 16983347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Death receptor 4 (DR4) efficiently kills breast cancer cells irrespective of their sensitivity to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
    Kazhdan I; Marciniak RA
    Cancer Gene Ther; 2004 Oct; 11(10):691-8. PubMed ID: 15354201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II.
    Ravi R; Bedi A
    Cancer Res; 2002 Aug; 62(15):4180-5. PubMed ID: 12154014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smac induces cytochrome c release and apoptosis independently from Bax/Bcl-x(L) in a strictly caspase-3-dependent manner in human carcinoma cells.
    Hasenjäger A; Gillissen B; Müller A; Normand G; Hemmati PG; Schuler M; Dörken B; Daniel PT
    Oncogene; 2004 Jun; 23(26):4523-35. PubMed ID: 15064710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic interactions of chemotherapeutic drugs and tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand on apoptosis and on regression of breast carcinoma in vivo.
    Singh TR; Shankar S; Chen X; Asim M; Srivastava RK
    Cancer Res; 2003 Sep; 63(17):5390-400. PubMed ID: 14500373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines.
    Henkels KM; Turchi JJ
    Cancer Res; 1999 Jul; 59(13):3077-83. PubMed ID: 10397248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct stress and cell destruction pathways are engaged by TNF and ceramide during apoptosis of MCF-7 cells.
    Donato NJ; Klostergaard J
    Exp Cell Res; 2004 Apr; 294(2):523-33. PubMed ID: 15023539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis induced by vitamin D compounds in breast cancer cells is inhibited by Bcl-2 but does not involve known caspases or p53.
    Mathiasen IS; Lademann U; Jäättelä M
    Cancer Res; 1999 Oct; 59(19):4848-56. PubMed ID: 10519395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of tumor necrosis factor alpha in hyperthermia-induced apoptosis of human leukemia cells.
    Katschinski DM; Robins HI; Schad M; Frede S; Fandrey J
    Cancer Res; 1999 Jul; 59(14):3404-10. PubMed ID: 10416602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selenocystine induces caspase-independent apoptosis in MCF-7 human breast carcinoma cells with involvement of p53 phosphorylation and reactive oxygen species generation.
    Chen T; Wong YS
    Int J Biochem Cell Biol; 2009 Mar; 41(3):666-76. PubMed ID: 18718551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways.
    Suliman A; Lam A; Datta R; Srivastava RK
    Oncogene; 2001 Apr; 20(17):2122-33. PubMed ID: 11360196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basic fibroblast growth factor downregulates Bcl-2 and promotes apoptosis in MCF-7 human breast cancer cells.
    Wang Q; Maloof P; Wang H; Fenig E; Stein D; Nichols G; Denny TN; Yahalom J; Wieder R
    Exp Cell Res; 1998 Jan; 238(1):177-87. PubMed ID: 9457070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential induction of apoptosis by tumor necrosis factor-related apoptosis-inducing ligand in human ovarian carcinoma cells.
    Lane D; Cartier A; L'Espérance S; Côté M; Rancourt C; Piché A
    Gynecol Oncol; 2004 Jun; 93(3):594-604. PubMed ID: 15196850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing of prion protein sensitizes breast adriamycin-resistant carcinoma cells to TRAIL-mediated cell death.
    Meslin F; Hamaï A; Gao P; Jalil A; Cahuzac N; Chouaib S; Mehrpour M
    Cancer Res; 2007 Nov; 67(22):10910-9. PubMed ID: 18006836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The differential sensitivity of Bc1-2-overexpressing human breast tumor cells to TRAIL or doxorubicin-induced apoptosis is dependent on Bc1-2 protein levels.
    Ruiz de Almodóvar C; Ruiz-Ruiz C; Muñoz-Pinedo C; Robledo G; López-Rivas A
    Oncogene; 2001 Oct; 20(48):7128-33. PubMed ID: 11704839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.